The proteasome is a protease complex composed of a core particle (CP) and regulatory particles (RPs) that bind to both ends of the CP. ECM29 is a protein that associates with the proteasome and is involved in the maintenance and regulation of the proteasome assembly. However, ECM29 deficient mice can form functional proteasome. In this paper we sought to identify the mechanisms and/or proteins that help and allow the maintenance of the proteasome activity in the absence of ECM29. We analyzed the proteasome components of ECM29-deficient mice and identified Hsp90 as a protein associated with the proteasome. Furthermore, the inhibition of Hsp90 led to a partial disassembly of the proteasome only in ECM29-deficient cells. Those findings attest to the importance of Hsp90 for the maintenance of the proteasome integrity in the absence of ECM29.
Introduction
In eukaryote cells, the 26S proteasome is the main machinery for the degradation of short-lived proteins [1] [2] . The 26S proteasome is the result of the association of the 20S core particule (CP) with a regulatory particle (RP) PA700 (19S) at each of its extremity [3] [4] . The CP, site of the enzymatic activity, is a hollow cylindrical structure formed by four stacked α and β rings, arranged in a sequence αββα. Each of these rings is composed of 7 subunits (α1 -α7, β1 -β7) [5] [6] . The PA700 consists of a base subcomplex and a lid subcomplex. It pos-sesses the ability to bind, deubiquitylate and unfold targeted proteins prior to their degradation by the CP [7] - [11] . The CP can also bind to other RPs such as PA200, PA28α/β hetero-heptamer and PA28γ homo-heptamer. This will result in the formation of hybrid proteasomes with specific functions. For example, PA28α/β hetero-heptamer can associate with the CP and is involved in the immune response [12] - [15] . The absence of PA28γ homoheptamer leads to a retardation in cell proliferation [16] [17] . PA200 binding to the proteasome is necessary for a normal spermatogenesis [18] - [21] . Finally ECM29, a conserved HEAT-like repeat protein has been reported to bind to the CP and/or PA700 to maintain the 26S proteasome structure [22] - [25] . In addition to those particles, many other proteins are known to bind and possibly assist the function of the proteasome [26] - [28] .
The molecular chaperone Hsp90, one of the most abundant intracellular proteins (1% -2% of total cellular proteins), helps the final maturation of specific client proteins [29] . Its importance has been shown in various cellular processes such as signal transduction, intracellular transport and the response to oxidative stress [30] - [34] . In mammals, Hsp90α and Hsp90β are the two main isoforms of Hsp90. Hsp90α is inducible under stress conditions, while Hsp90β is constitutively expressed. Recent studies mainly in yeast also implied that Hsp90 is involved in the maintenance of the 26S structure of the proteasome [35] - [37] .
In an attempt to identify new proteasome components in the absence ofECM29, we surprisingly found a relationship between ECM29 and Hsp90 in the maintenance of the proteasome structure. To purify the proteasome, we used a slightly modified affinity method used by Legget et al. [23] in yeast. Here, we applied this method for the first time directly on the liver of WT and ECM29 deficient mice. After purification and analysis by Mass Spectrometry (MS), we identified Hsp90, and found that the amount of Hsp90α bound to the proteasome was higher in the ECM29 deficient mice. Furthermore, the inhibition of Hsp90 led to a partial dissociation of the proteasome only in ECM29 deficient cells. We also observed that the ECM29 KO cells were more resistant to the treatment by geldanamycin (GA), an Hsp90 inhibitor. Our data clearly show that, Hsp90 associates with the proteasome and helps to maintain the structure of the proteasome in mammalian cells. Moreover, those results suggest a cooperation between Hsp90 and ECM29 to maintain the structure of the proteasome.
Materials and Methods

Knock Out and Transgenic Mice
Kiaa0368 KO (ECM29 deficient) mice were generated, and its details will be published elsewhere. Transgenic mice that ubiquitously express HTBT-tagged Rpn11 (subunit of PA700 lid) were a gift from Professor Heiichiro Udono (Okayama University). The KO mice with the HTBT-tagged Rpn11 were obtained after several cycles of breeding. The mice genotypes were checked by PCR. The primers used for ECM29 were 5'-CCAGTGTAGCAG GAGTTCTTTCAGG-3', 5'-CATATTTGGTTTTAGATCAGTCCAG-3' and 5'-GATCAGGATGATCTGGACG AAGAG-3'. They amplified a WT band of 2.2 Kbp and a KO band of 600 bp. The primers used to check the presence of the HTBT-tagged Rpn11 were5'-TTGTGGATCCCATTCAGAGTGTAA-3' and 5'-TATCGTAGTC ATGATGGTGGTGAT-3'. They amplified a product length of 600 bp.
All animal experiments were performed in accordance with the guidelines of the University of Tsukuba's Regulation of Animal Experiments Committee.
Preparation of MEFs and Cell Culture
Mouse embryonic fibroblast (MEF) cells were isolated from 13.5 days post coitus embryos and cultured in Dulbecco's modified Eagle's medium (D-MEM, high glucose) (Wako) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (Invitrogen) at 37˚C, 5% CO 2 . MEFs were immortalized by transfecting SV40 large T antigen (kindly provided from Dr. N. Mizushima [The University of Tokyo, Japan]) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction.
Cell Viability Assay
The MEF cells (WT and ECM29 deficient) were seeded into a 96-well plate at 5000 cells/well and grown for 24 h. The growing medium was replaced by Geldanamycin (GA) (250 nM or 750 nM) or 0.5% DMSO (control) in D-MEM and the cells were incubated for 48 h. The cell proliferation assay was then conducted according to the manufacturer's instructions (Cell Counting Kit 8, Dojindo). The results are expressed as the relative viability of cells compared to their respective control.
Cells Extract Preparation and Glycerol Density Gradient Centrifugation
The cells were lysed in 500 μl buffer (50 mM TrisHCl (pH 7.5), 5 mM MgCl 2 , 0.5% NP-40, 2 mM ATP and 1mM DTT) for 30 min on ice. The lysate was cleared by centrifugation for 30 min at 15,000 g and the supernatant was collected. 600 μl of cell lysates were separated by 10% -40% glycerol density gradient centrifugation (GDGC) for 22 h at 25,000 rpm at 4˚C (Beckman Coulter Optima-LE 80k Ultracentrifuge, SW41 rotor). The gradients were fractionated using liquid layer injector fractionator (ADVANTEC) equipped with fraction collector (ATTO).
Purification of the Proteasome
The mouse livers were dissected and homogenized in 5 volumes per liver's weight of buffer A (25 mM TrisHCl (pH 7.5), 10% Glycerol, 5 mM MgCl 2 , 1 mM PMSF, 5 mM ATP). The lysate was cleared by centrifugation for 20 min at 10,000 rpm. The supernatant was kept and mixed with 250 µl Streptavidine-Sepharose's high performance beads (GE healthcare) overnight in cold room. The beads were collected, washed twice in buffer A and mixed with 2% (v/v) of AcTEV (Novex) at 30˚C for 2 h. The mix was centrifuged at 10,000 rpm for 1 min and the eluates were collected. The elution step was repeated 6 times.
Mass Spectrometry Analysis
The MS analyses were performed as previously described [38] . In brief, the excised spots from the gel were rinsed with 100 μl (50 mM ammonium bicarbonate (NH 4 HCO 3 ) solution in 50% acetonitrile) and vacuum-dried. For the in-gel digestion, we added 2 μl of trypsin solution (10 mM NH 4 HCO 3 and 10 ng/μl of trypsin), and incubated at 37˚C for 4 h to overnight. The peptides were extracted with 10 µl (75% ACN containing 0.025% trifluoroacetic acid) by ultrasonication. The spot on the MALDI sample plate was loaded with 0.5 μl of the matrix (α-Cyano-4-hydroxycinnamic acid (4-CHCA, Shimadzu Biotech, Kyoto, Japan) and 1 μl of the peptide sample solution. The samples were analyzed by the AXIMA Performance MALDI-TOF-MS (Shimadzu Biotech, Kyoto, Japan) and identified by Peptide Mass Fingerprint (PMF) analysis.
Electrophoresis and Western Blot
Native-PAGE was performed using 3% -10% gradient gels (Wako Pure Chemical Industries) in electrophoresis buffer (180 mM Tris borate (pH 8.3). Protein samples were mixed with xylene cyanol, run at 100 V until the xylene cyanol dye exited the gel and transferred to PVDF membrane.
Purified proteasome, cleared lysate or GDGC fractions were mixed with 2 × SDS sample buffer, separated by SDS-PAGE and transferred to PVDF membrane.
The membrane was probed with primary antibodies, HRP-conjugated secondary antibodies, and then detected with chemiluminescence reagent (Amersham ECL plus Western Blotting Detection Reagents, GE Healthcare).
Antibodies
Anti-PA28γ monoclonal (BD Transduction Laboratories; 611,180), anti-β5 rabbit polyclonal (Abcam; ab3330), anti-Hsp86 rabbit polyclonal (thermo scientific), anti-PA200 rabbit polyclonal (Santa Cruz Biotechnology) and Peroxidase-conjugated anti-rabbit or anti-mouse (Jackson Immuno Research) antibodies were purchased. Anti-ECM29 and anti-β7 antibodies were raised from rabbit using the recombinant his-tagged β7 and the recombinant his-tagged ECM29 (100 C-terminal amino acid). Anti-PA28α and anti-Rpt1 antibodies are described previously [39] [40].
Proteasome Activity
2 μl of purified proteasome were mixed with 98 μl of buffer (100 mM TrisHCl (pH 7.5) and 0.01 mM of fluorescent substrate (N-suc-leu-leu-val-tyr-AMC) (Peptide Institute)) and incubated at 37˚C. The fluorescence was read on the 1420 Multilabel counter (Perkin Elmer ex355/em410). For each purified proteasome, the concentration was measured by Bradford assay and the protease activity is as the N-suc-LLVY-AMC hydrolysis/ng/min. 10 μl of GDGC fraction was mixed with 90 μl of buffer (100 mM TrisHCl (pH 8.0), 50 mM KCl, 10 mM MgCl 2 , 0.056 mM of fluorescent substrate (N-suc-leu-leu-val-tyr-AMC), 1.12 mM ATP and 39 μl of water). The fluorescence was read on the 1420 Multilabel counter (Perkin Elmer ex355/em410).
Statistical Analysis
Student's t-tests were performed for statistical analyses. Data in all graphs are presented as means ± S.D.
Results
Purification of Functional Proteasomes from Mice Liver
The purification method for yeast proteasome by HTBH-tagged Rpn11 was described previously by Leggett et al. [23] [41]. We followed the same method using WT and ECM29 deficient mice with HTBH-tagged Rpn11 (Figure 1(a) ). The purified samples (Figure 1(b) ) had an SDS-PAGE profile similar to the ones obtained by previous studies [23] [41] . It has been shown that the presence of 100 -500 mM of NaCl is sufficient to dissociate proteins associated to the proteasome [7] [23] [42] . During the purification process on WT mice, we washed the proteasome bound to the streptavidin beads with buffer A containing an increasing concentration of NaCl (50, 100, 150, 200, 250 and 300 mM). The Eluate of each of the washing step was then analyzed by west- ern blot (WB) of proteasome associated proteins (ECM29, PA200, PA28α) (Figure 1(c) ). We noticed that lower concentration of NaCl (from 50 mM) also causes the dissociation of these proteins associated to the proteasome (Figure 1(c) ). To avoid losing proteins associated to the proteasome, we excluded the NaCl and the surfactant from the purification buffer in following analyses. The SDS-PAGE profile of the proteasome purified by the modified buffer contained more bands (Figure 1(d) and Figure 1(e) ), showing that more proteins were co-purified with the proteasome.
To assert that we purified functional proteasomes, we first checked the peptidase activity of the purified samples from WT and ECM29 deficient mice. A significant protease activity was detected for the purified samples compared to the control (mice with no tag) (Figure 2(a) ). This result was consistent with findings of a previous study showing that ECM29 inhibits the peptidase activity of the proteasome [43] . It also proved that there is no unspecific binding of the proteasome to the streptavidin beads.
Finally, we confirmed by WB the presence of the CP subunit, the PA700, PA200, PA28α and PA28γ. According to the results, our method retained the CP, the PA700 and other known associated proteins such as PA200, PA28α, PA28γ and ECM29 (Figure 2(b) ). The WB of the control also showed that the purification of these proteasome components is specific. Taken together, these data confirmed that our modified method could purify an active proteasome including hybrid proteasomes directly from the liver.
More Hsp90 Bind to the Proteasome in the Absence of ECM29
Next, we analyzed the components of the purified proteasome by MS and identified Hsp90α and Hsp90β as candidate proteins. The presence of Hsp90α and the specificity of its association with the proteasome was further confirmed by WB of the purified samples from WT, ECM29 deficient and control mice (Figure 3(a) ). Interestingly, we found that the quantity of Hsp90α binding to the proteasome was higher in the case of the ECM29 deficient mice (Figure 3(a) and Figure 3(b) ). Hsp90 is a stress-induced chaperone protein in mammalian cells. The variation observed might be a result of the increase of the total cytosolic Hsp90 in ECM29 KO condition. To eliminate this possibility, we checked the amount of Hsp90 in the lysate of liver from WT and ECM29 deficient mice (Figure 3(c) and Figure 3(d) ). No noticeable variation was observed. Taken together our data imply a link between Hsp90 function and the absence of ECM29. * p < 0.005. n.s. not significant.
Hsp90 Helps to Maintain the Proteasome Integrity
As ECM29 has been reported to stabilize the 26S proteasome complex in yeast, we focused on the proteasome structure. To elucidate the functional link between Hsp90 and ECM29 on the structure of the proteasome, we ran a glycerol density gradient centrifugation experiment (GDGC) with WT and ECM29 deficient cell lysates following treatment with Geldanamycin (GA), an inhibitor of Hsp90. We then checked the proteasome activity of each fraction. GA treatment induced no differences for the WT cells (Figure 4(a) ), but the peak of the proteasome activity shifted from the 20 th fraction to the lighter 19 th fraction in ECM29 deficient cells (Figure 4(b) ). This shift suggests a partial disassembly of the proteasome, and these results imply that the presence of ECM29 stabilizes the proteasome structure when Hsp90 is absent. In ECM29 deficient cells, the shift correlated with the decrease of Hsp90α present in the fraction of maximum activity upon GA treatment (Figure 4(b) ). However, no noticeable decrease of Hsp90α was observed for the WT lysate (Figure 4(a) ).This may suggest a preferential binding of Hsp90 to the proteasome in the absence of ECM29.
To confirm the direct effect of Hsp90 on the proteasome and avoid any interference by the components of the lysates, we treated the purified proteasome with GA. Native-PAGE followed by WB showed that GA treatment of the proteasome lacking ECM29 led to an increase in intermediate varieties of proteasome and lower molecular weight sub-complex containing RPT1, a subunit of PA700 (Figure 5(a) and Figure 5(d) ). Likewise, in the proteasome lacking ECM29, the GA treatment led also to the increase in intermediate varieties of proteasome containing β5, a subunit of the CP (Figure 5(b) and Figure 5(e) ). Western blots against PA200, PA28α or PA28γ did not show any differences, suggesting that Hsp90 is not involved in the association or dissociation of these RPs even in the absence of ECM29 (Figure 5(c), Figure 5 (f) and data not shown). Taken together, these results suggest that in the absence of ECM29, the inhibition of Hsp90 causes a dissociation of the PA700 from the CP proteasome.
ECM29 Deficient Cells are More Resistant to GA Treatment
Finally we checked the impact of the GA treatment on the survival of WT and ECM29-deficient cells. We present the cell viability by the percentage of viable cells compared to the control cells (WT and ECM29 deficient cells treated with DMSO only) to account for a possible difference of growth rates. Surprisingly, we found that ECM29 deficient cells were more resistant to the GA treatment (Figure 6 ). 
Discussion
The proteasome is involved in numerous cellular processes and its dysfunction leads to serious diseases. A major challenge to understand this complex is to identify the proteins that associate with the proteasome and to elucidate the effect of those proteins on the proteasome. To achieve this goal we based our strategy on the purification of the proteasome by a very efficient and gentle technique using an HTBH-tag. For the first time, we ap- plied this method directly on WT and ECM29 deficient mice liver and identified Hsp90 by MS. In mammalian cells, only one study discussed the involvement of Hsp90 in the proteasome assembly in vitro [37] . In yeast, previous studies [35] [36] revealed an interaction between the proteasome and Hsp90. Imai et al. [35] reported that Hsp90 plays a role in the maintenance of the proteasome structure, since the proteasome of the yeast Hsp90 mutant was disassembled at non-permissive temperature. They also reported that the GA-treatment of wild-type yeast proteasome didn't lead to the disassembly of the 26S structure.
In the present study, we confirm by MS and WB that Hsp90 is associated with the proteasome in mammalian cells. We find that the amount of Hsp90 associates to the proteasome is higher in the absence of ECM29. We also shed more light on the function of Hsp90 and ECM29 which helps to maintain the 26S structure of the proteasome. Indeed, we reveal a link between the Hsp90 and ECM29 functions since GA treatment led to the partial dissociation of the proteasome only in the absence of ECM29. Our data suggest that ECM29 stabilizes the proteasome structure after Hsp90 has completed its function. This explains why the inhibition of Hsp90 doesn't lead to the dissociation of the proteasome in the WT lines. Accordingly, in the absence of ECM29, the inhibition of Hsp90 leads to the disassembly of the 26S proteasome.
Curiously, in the GDGC experiment, the GA treatment of the WT lysates didn't lead to a marked shift of Hsp90 around the fraction of maximum proteasome activity as observed in the ECM29 deficient cell lysates (Figure 4(a), Figure 4(b) ). As explained by Schneider et al. [44] , Hsp90 can still remain bound to its protein client while inhibited. In this case, the decrease of Hsp90 observed in the ECM29 deficient cells (Figure 4(b) ) would be the consequence of the dissociation of PA700 from CP and couldn't be observed in WT cells since there was no dissociation. Also, we detected Hsp90 in the heaviest fractions of WT cells but not of ECM29 deficient cells (Figure 4(a) and Figure 4(b) ). Since Hsp90 stabilizes the structure of the proteasome in the absence of ECM29, Hsp90 would be mostly bound to the proteasome. In the WT cells, Hsp90 is free from this role by the presence of ECM29 and bind to other client proteins present in the heaviest fractions. This may suggest a preferential binding of Hsp90 to the proteasome in the absence of ECM29.
GA treatment of cells causes a disruption of Hsp90 protein clients and an increase in reactive oxygen species (ROS) level leading to the cell death [45] . Previous studies imply that an increase in CP and hybrid proteasomes helps the cells to eliminate the ROS more efficiently [46] - [48] . We have shown that, upon GA treatment, a partial dissociation of the 26S occurs in the absence of ECM29. This means that in ECM29 deficient cells, the formation of CP and hybrid proteasomes is facilitated, ensuring a better elimination of ROS and thus a better viability (Figure 6) .
Taken together, our data provide a better understanding of how the structure of the proteasome is maintained and show a functional link between ECM29 and Hsp90 on the proteasome structure. However, the precise me-chanism of this relation under normal and stress conditions must be thoroughly investigated in the future.
